Gilead Sciences Inc.’s recently made public that its Chief Financial Officer Dickinson Andrew D unloaded Company’s shares for reported $0.4 million on Jul 20. In the deal valued at $80.00 per share,5,000 shares were sold. As a result of this transaction, Dickinson Andrew D now holds 107,587 shares worth roughly $ 8.09 million.
Then, GILEAD SCIENCES, INC. bought 1,010,000 shares, generating $19,452,600 in total proceeds. Upon buying the shares at $19.26, the 10% Owner now owns 14,823,029 shares.
Before that, GILEAD SCIENCES, INC. bought 2,930,870 shares. Gilead Sciences Inc. shares valued at $10,990,762 were divested by the 10% Owner at a price of $3.75 per share. As a result of the transaction, GILEAD SCIENCES, INC. now holds 16,635,286 shares, worth roughly $1.25 billion.
Barclays reiterated its Gilead Sciences Inc. [GILD] rating to an Equal weight in a research note published on Tuesday, July 24, 2023; the price target was $80. PT values the company’s stock at a premium of 6.05 to its Tuesday closing price.
Price Performance Review of GILD
On Tuesday, Gilead Sciences Inc. [NASDAQ:GILD] saw its stock fall -1.94% to $75.16. On the same session, the stock had its day’s lowest price of $75.13, but rose to a high of $77.00. Over the last five days, the stock has lost -2.44%. Gilead Sciences Inc. shares have fallen nearly -12.45% since the year began. Nevertheless, the stocks have risen 15.72% over the past one year. While a 52-week high of $89.74 was reached on 01/06/23, a 52-week low of $61.44 was recorded on 07/07/23. SMA at 50 days reached $77.31, while 200 days put it at $81.19. A total of 6.05 million shares were traded, compared to the trading of 2.99 million shares in the previous session.
Levels Of Support And Resistance For GILD Stock
The 24-hour chart illustrates a support level at 74.53, which if violated will result in even more drops to 73.89. On the upside, there is a resistance level at 76.40. A further resistance level may holdings at 77.63. The Relative Strength Index (RSI) on the 14-day chart is 38.82, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.62, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 99.45%. Stochastics %K at 16.75% indicates the stock is a buying.
How much short interest is there in Gilead Sciences Inc.?
A steep rise in short interest was recorded in Gilead Sciences Inc. stocks on Aug 14, 2023, growing by 2.06 million shares to a total of 19.63 million shares. Yahoo Finance data shows the prior-month short interest on Jul 13, 2023 was 17.57 million shares. There was a rise of 10.49%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 1.76% of the overall stock float, the days-to-cover ratio (short ratio) rose to 3.31.
Gilead Sciences Inc. [GILD] – Who Are The Largest Shareholders?
In filings from The Vanguard Group, Inc., it is revealed that the company now owns 108,008,385 shares, or roughly 8.66% of the outstanding GILD shares. In other words, the investor’s shares have risen by 473,764 from its previous 13-F filing of 107534621.0. Additionally, BlackRock Fund Advisors decreased -0.82% of its stake after which the total value it holdings stand at $6,169,413,597, while Capital Research & Management Co added 5.79% of its stake to hold $6.16 billion in the firm. Over the last quarter, SSgA Funds Management, Inc. purchased 1,514,894 shares of Gilead Sciences Inc., while Capital Research & Management Co bought -378,438 shares. At present, Dodge & Cox is holding 33,979,757 shares valued at $2.59 billion. Geode Capital Management LLC owned 24,212,636 shares of the company at the time of its most recent 13F filing, worth $1.84 billion.
According to FactSet, Gilead Sciences Inc.’s share price will average $90.55 in the next year, based on opinions of analysts polled by the firm. This is up nearly 17.42 percent from its previous closing price of $76.65. Analysts expect Gilead Sciences Inc. stock to reach the higher price of $116.00, while the lowest price estimate is $71.00. However, 30 analysts have rated GILD stock as an Overweight in their predictions for 2023.